3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. (September 2015) - Tamiya, A.